AFT Pharmaceuticals Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
276 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pyrazinamide-AFT pyrazinamide 500 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOXIFLOXACIN-AFT moxifloxacin (as hydrochloride) 400 mg / 250 mL intravenous infusion injection bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MAGNESIUM SULFATE-AFT magnesium sulfate heptahydrate 2.5 g/5 mL concentrated injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHENYLEPHRINE-AFT phenylephrine hydrochloride 10 mg/1 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT Pharmaceuticals Pty Ltd - Lubricant, eye.
-
Cancellation by sponsorRequested by AFT Pharmaceuticals Pty Ltd
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Ertapenem-AFT ertapenem (as sodium) 1 g powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ferro-f-tab tablet blister (new formulation).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ferro-tab tablet blister (new formulation).